Novartis India (NOVARTIND) Share Price falls 8.63% as market cap stands at Rs 4,747.79 crore
- September 15, 2026
- Posted by: Kunal Singla
- Category: News
Novartis India Share Price moved lower today, with the stock last traded at Rs 1,757, down 8.63% from the previous close of Rs 1,922.90. The company’s market capitalisation stood at Rs 4,747.79 crore, placing it in the Small Cap category. Univest data confirms the move itself, though no company-specific trigger has been identified. The move matters because Novartis India Share Price is trading well below the prior close while key fundamentals remain available for comparison, including a P/E of 48.56, P/B of 5.59, ROE of 11.63% and ROCE of 16.34%.
For readers tracking Novartis India Share Price Today, the intraday range was narrow but decisive: the stock opened at Rs 1,890, touched a high of Rs 1,890 and a low of Rs 1,757. Novartis India Share Price therefore showed a clear one-session decline from the opening level to the current price. The company’s size and valuation profile make the move relevant for investors following Novartis India Share Price News, especially when comparing the stock with the wider Trading universe and its own fundamentals. The next sections place the share price fall in price action, valuation and peer context.
Novartis India (NOVARTIND) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,757 |
| Previous Close | Rs 1,922.9 |
| Today's Move | -Rs 165.90 (-8.63%) |
| Open | Rs 1,890 |
| High | Rs 1,890 |
| Low | Rs 1,757 |
| Market Capitalisation | Rs 4,747.79 crore |
| Market Cap Category | Small Cap |
Novartis India Share Price Today shows a fall of Rs 165.90 from the previous close, or 8.63%, with the stock last traded at Rs 1,757 as of 21 October 2026 at 3:23:11 PM IST. The day opened at Rs 1,890, which was also the high for the move, and the low was Rs 1,757. That sequence shows that Novartis India Share Price weakened through the trading window rather than recovering back to the opening level. The current market capitalisation of Rs 4,747.79 crore keeps Novartis India Share Price within the Small Cap category and gives the move company-specific weight in the day’s market discussion.
In simple terms, the share price news is a straightforward decline from the prior session’s reference point. Novartis India Share Price did not build on the opening level, and the day’s low matched the latest traded price. For anyone following Novartis India Share Price Live, that makes the current level an important reference for stock performance tracking. The price action section leads naturally into the fundamentals, because a sharp change in Novartis India Share Price is best read alongside valuation, earnings efficiency and book value.
Novartis India (NOVARTIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,747.79 crore |
| P/E Ratio | 48.56x |
| P/B Ratio | 5.59x |
| ROE | 11.63% |
| ROCE | 16.34% |
| EPS | Rs 39.6 |
| Book Value Per Share | Rs 344.28 |
| Dividend Yield | 0% |
Novartis India (NOVARTIND) fundamental metrics show P/E 48.56x, P/B 5.59x, ROE 11.63%, ROCE 16.34%. Read together, these ratios describe the company’s position rather than a recommendation.
Novartis India has a market capitalisation of Rs 4,747.79 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.56x, P/B at 5.59x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.63% and ROCE of 16.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 39.6, book value per share of Rs 344.28, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 21.95x, median ROE of 4.18%, median ROCE of 6.04%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.56x |
| Benchmark Median P/E | 21.95x |
| Benchmark Average P/E | 87.9x |
| Benchmark P/E Range | 0.14x to 3,170.85x |
| Company P/B Ratio | 5.59x |
| Benchmark Median P/B | 1.34x |
| Benchmark Average P/B | 2.63x |
| Company ROE | 11.63% |
| Benchmark Median ROE | 4.18% |
| Benchmark Average ROE | 4.3% |
| Company ROCE | 16.34% |
| Benchmark Median ROCE | 6.04% |
| Benchmark Average ROCE | 7.3% |
| Company Market Capitalisation | Rs 4,747.79 crore |
| Benchmark Median Market Cap | Rs 53.16 crore |
| Benchmark Average Market Cap | Rs 1,504.75 crore |
Novartis India (NOVARTIND) operates in the Trading sector, within the Trading industry.
Novartis India (NOVARTIND) has a P/E ratio of 48.56x, which is above the benchmark median of 21.95x, a difference of +121.23%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Novartis India (NOVARTIND) has a ROE of 11.63%, which is above the benchmark median of 4.18%, a difference of +178.23%. Novartis India (NOVARTIND) has a ROCE of 16.34%, which is above the benchmark median of 6.04%, a difference of +170.53%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Adani Enterprises | ADANIENT | 3,59,548.72 | 48.3 | 3.81 | 15.07 | 13.3 |
| ADITYA INFOTECH | CPPLUS | 49,162.37 | 103 | 13.98 | 25.68 | 29.48 |
| Aegis Logistics | AEGISLOG | 46,749.69 | 37.36 | 7.08 | 20.71 | 19.76 |
| Premier Energies | PREMIERENE | 40,821.59 | 24.52 | 8.59 | 42.6 | 33.72 |
| Redington | REDINGTON | 29,003.83 | 17.05 | 2.73 | 13.6 | 18.96 |
Novartis India (NOVARTIND) has a P/E ratio of 48.56x compared with the displayed peer median of 37.36x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 11.63% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 16.34% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Novartis India (NOVARTIND) has a market capitalisation of Rs 4,747.79 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Novartis India
- Novartis India Share Price fell 8.63% in one trading move, taking the stock to Rs 1,757.
- The opening level of Rs 1,890 was not revisited after the high, so Novartis India Share Price stayed weak through the day.
- Valuation remains elevated, with P/E at 48.56 and P/B at 5.59.
- ROE of 11.63% and ROCE of 16.34% give context to Novartis India Fundamental Analysis.
- Novartis India Share Price is small-cap in size but larger than the median company in the same industry benchmark.
About Novartis India
Novartis India operates in the Trading sector and Trading industry. The company’s current market capitalisation is Rs 4,747.79 crore, and the latest valuation data places Novartis India Share Price at a P/E of 48.56 and a P/B of 5.59. In company overview terms, the available figures point to a listed business with return ratios of 11.63% ROE and 16.34% ROCE, supported by EPS of Rs 39.60 and book value of Rs 344.28 per share. The core read-through for Novartis India Share Price is that the stock is positioned as a valued trading-name with a meaningful scale relative to the wider industry set.
Track Novartis India Share Price on Univest
Use Novartis India (NOVARTIND) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Novartis India Share Price on Univest for live share price updates, valuation ratios, 52-week levels and market insights. Univest also brings together Novartis India stock news, fundamental ratios and market cap context in one place. If you follow Novartis India Share Price Today, the platform helps you stay aligned with price action, sector comparison and the latest company context without switching between multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Novartis India Share Price fall today?
Ans. Novartis India Share Price fell 8.63% to Rs 1,757 from the previous close of Rs 1,922.90. According to Univest data, the price event is confirmed, but no company-specific catalyst is established for the move.
What is Novartis India Share Price today?
Ans. Novartis India Share Price was last traded at Rs 1,757 as of 21 October 2026 at 3:23:11 PM IST. The stock moved lower from the previous close and remained below the opening level of Rs 1,890.
How much did Novartis India Share Price decline in percentage terms?
Ans. Novartis India Share Price declined 8.63% in the latest session. The absolute fall was Rs 165.90, which took the stock from Rs 1,922.90 at the previous close to Rs 1,757 during the trading day.
What is the market capitalisation of Novartis India?
Ans. Novartis India has a market capitalisation of Rs 4,747.79 crore. That places Novartis India Share Price in the Small Cap category and gives the move context relative to a company that is larger than the median trading-name in the benchmark.
What is Novartis India Share Price valuation today?
Ans. Novartis India Share Price has a P/E of 48.56 and a P/B of 5.59. The stock also has EPS of Rs 39.60 and book value of Rs 344.28 per share, which are useful anchors for valuation analysis.
How does Novartis India compare with the Trading sector benchmark?
Ans. Novartis India Share Price trades above the same-industry median on P/E, P/B, ROE and ROCE. Its P/E of 48.56 is above the benchmark median of 21.95, while ROE and ROCE are also above the benchmark averages.
Is Novartis India Share Price expensive compared with peers?
Ans. Novartis India Share Price is not the lowest-valued in the peer set. Its P/E of 48.56 is above Aegis Logistics and Redington, below CPPLUS and above Adani Enterprises by a narrow margin. On P/B, it sits in the middle of.
What do ROE and ROCE say about Novartis India?
Ans. Novartis India reports ROE of 11.63% and ROCE of 16.34%. Those figures are above the same-industry medians, which means Novartis India Share Price is backed by returns that compare favourably with the wider Trading benchmark.
Where can investors track Novartis India Share Price news?
Ans. Investors can track Novartis India Share Price news on Univest for live price updates, valuation ratios, market cap context and company-level stock news. The page also helps follow the stock alongside sector and peer comparisons.